Quantum-Si (QSI) Scheduled to Post Earnings on Tuesday

Quantum-Si (NASDAQ:QSI) is scheduled to be announcing its earnings results before the market opens on Tuesday, November 12th. Analysts expect the company to announce earnings of ($0.21) per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

Quantum-Si (NASDAQ:QSI) last posted its quarterly earnings results on Wednesday, August 7th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.21) by $0.05. Quantum-Si had a negative return on equity of 33.02% and a negative net margin of 5,249.65%. The firm had revenue of $0.62 million during the quarter, compared to analyst estimates of $0.66 million. On average, analysts expect Quantum-Si to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Quantum-Si Stock Performance

Shares of QSI stock opened at $0.94 on Friday. The company has a market capitalization of $133.80 million, a price-to-earnings ratio of -1.49 and a beta of 2.89. Quantum-Si has a one year low of $0.70 and a one year high of $2.43. The company’s 50-day moving average is $0.86 and its 200 day moving average is $1.13.

Insider Buying and Selling

In other news, Director Charles R. Kummeth acquired 31,100 shares of the business’s stock in a transaction that occurred on Monday, August 12th. The stock was bought at an average price of $0.89 per share, with a total value of $27,679.00. Following the completion of the acquisition, the director now directly owns 355,000 shares of the company’s stock, valued at approximately $315,950. The trade was a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 30.04% of the stock is currently owned by corporate insiders.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.